Barclays’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
|
|||||
|
2025
Q1 | $766K | Buy |
|
|||||
|
2024
Q4 | $252K | Sell |
|
|||||
|
2024
Q3 | $283K | Buy |
|
|||||
|
2024
Q2 | $18K | Sell |
|
|||||
|
2024
Q1 | $190K | Sell |
|
|||||
|
2023
Q4 | $369K | Buy |
|
|||||
|
2023
Q3 | $189K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $587K | Buy |
|
|||||
|
2022
Q3 | $118K | Buy |
|
|||||
|
2022
Q2 | $79K | Buy |
|